Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study
暂无分享,去创建一个
K. Shirabe | N. Harimoto | S. Kakizaki | Ken Sato | T. Uraoka | H. Tojima | D. Takizawa | A. Naganuma | M. Namikawa | T. Hatanaka | Y. Shimada | H. Arai | T. Nagashima